Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Finasteride forms three new products under acidic stress.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.